MCID: GMS001
MIFTS: 45

Gemistocytic Astrocytoma malady

Categories: Neuronal diseases, Cancer diseases, Rare diseases

Aliases & Classifications for Gemistocytic Astrocytoma

About this section
Sources:
10Disease Ontology, 47Novoseek, 12DISEASES, 51Orphanet, 65UMLS, 36MeSH, 42NCIt, 59SNOMED-CT, 66UMLS via Orphanet
See all MalaCards sources

Aliases & Descriptions for Gemistocytic Astrocytoma:

Name: Gemistocytic Astrocytoma 10 47 12 51 65
 
Gemistocytic Astrocytic Tumor 10

Classifications:



External Ids:

Disease Ontology10 DOID:7005
MeSH36 D001254
NCIt42 C4321
SNOMED-CT59 73982001
Orphanet51 251604
UMLS via Orphanet66 C0334581
UMLS65 C0334581

Summaries for Gemistocytic Astrocytoma

About this section
MalaCards based summary: Gemistocytic Astrocytoma, also known as gemistocytic astrocytic tumor, is related to astrocytoma and subependymal giant cell astrocytoma, and has symptoms including sensory manifestations, motor manifestations and seizures. An important gene associated with Gemistocytic Astrocytoma is IDH2 (Isocitrate Dehydrogenase (NADP(+)) 2, Mitochondrial), and among its related pathways are Central carbon metabolism in cancer and Small cell lung cancer. Affiliated tissues include brain, breast and kidney, and related mouse phenotypes are tumorigenesis and muscle.

Related Diseases for Gemistocytic Astrocytoma

About this section

Diseases related to Gemistocytic Astrocytoma via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 125)
idRelated DiseaseScoreTop Affiliating Genes
1astrocytoma31.4GFAP, IDH1, PTEN, TP53
2subependymal giant cell astrocytoma30.8GFAP, IDH1, TP53
3giant cell glioblastoma29.5ENO2, GFAP, IDH1, PTEN, S100B, TP53
4fibrillary astrocytoma11.3
5oligodactyly tetramelic postaxial10.9GFAP, IDH2
6alveoli adenoma10.8GFAP, TP53
7pineal gland astrocytoma10.8GFAP, TP53
8paranasal sinus lymphoma10.8IDH1, IDH2
9brain oligodendroglioma10.8IDH1, IDH2
10enchondromatosis dwarfism deafness10.7IDH1, IDH2
11ovary neuroendocrine neoplasm10.7PTEN, TP53
12anaplastic ganglioglioma10.7GFAP, PTEN, S100B
13ovarian mucinous cystadenofibroma10.7GFAP, IDH2, TP53
14lateral ventricle meningioma10.7GFAP, TP53
15headache10.7GFAP, S100B
16hypogonadotropic hypogonadism-frontoparietal alopecia syndrome10.7IDH1, TP53
17renal tubular acidosis, distal, autosomal recessive10.7GFAP, PTEN, S100B
18hypothyroidism due to deficient transcription factors involved in pituitary development or function10.7GFAP, S100B, TP53
19juxtacortical osteosarcoma10.7IDH1, IDH2
20pilocytic astrocytoma10.7IDH1, TP53
21diencephalic astrocytomas10.7IDH1, IDH2
22cervical endometrial stromal sarcoma10.6GFAP, S100B, TP53
23mannosidosis10.6GFAP, PTEN, TP53
24acute pyelonephritis10.6ERCC1, TP53
25anaplastic plasmacytoma10.6IDH1, IDH2
26mixed astrocytoma-ependymoma10.6IDH1, IDH2, TP53
27grade iii astrocytoma10.6IDH1, IDH2, PTEN
28bronchitis10.6GFAP, IDH1, PTEN
29urinary bladder villous adenoma10.6GFAP, SYP
30salivary gland adenoid cystic carcinoma10.5GFAP, IDH1, TP53
31pediculus humanus capitis infestation10.5GFAP, SYP
32hypoplastic left heart syndrome10.5GFAP, PTEN, TP53
33childhood medulloblastoma10.5ENO2, GFAP
34complement component 3 deficiency10.5GFAP, SYP
35adult malignant schwannoma10.5GFAP, SYP
36juvenile astrocytoma10.5GFAP, IDH2, PTEN, TP53
37breast myofibroblastoma10.5IDH1, IDH2
38clivus chondroid chordoma10.5CXCL12, PTEN
39brain glioma10.5SYP, TP53
40benign ependymoma10.5GFAP, SYP
41uterine inflammatory disease10.4ITGA2, TERT
42vibratory urticaria10.4ERCC1, PTEN, TP53
43anovulation10.4GFAP, S100B, SYP
44mixed glioma10.4GFAP, S100B, SYP
45skin glomus tumor10.4GFAP, PTEN, SYP
46ependymoblastoma10.4GFAP, S100B, SYP
47congenital disorder of glycosylation, type if10.4GFAP, IDH1, IDH2, TP53
48dubin-johnson syndrome10.4PTEN, TERT, TP53
49colon small cell carcinoma10.4GFAP, IDH1, IDH2, TP53
50cerebellar medulloblastoma10.4GFAP, SYP, TP53

Graphical network of the top 20 diseases related to Gemistocytic Astrocytoma:



Diseases related to gemistocytic astrocytoma

Symptoms for Gemistocytic Astrocytoma

About this section

UMLS symptoms related to Gemistocytic Astrocytoma:


sensory manifestations, motor manifestations, seizures, headache

Drugs & Therapeutics for Gemistocytic Astrocytoma

About this section

Drugs for Gemistocytic Astrocytoma (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 23)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
CyproheptadineapprovedPhase 315129-03-32913
Synonyms:
1-Methyl-4-(5-dibenzo(a,e)cycloheptatrienylidene)piperidine
1-Methyl-4-(5H-dibenzo(a,d)cycloheptenylidene)piperidine
1-methyl-4-(5-dibenzo(a,e)cycloheptatrienylidene)piperidine
129-03-3
4-(5-Dibenzo(a,D)cyclohepten-5-ylidine)-1-methylpiperidine
4-(5-Dibenzo(a,d)cyclohepten-5-ylidine)-1-methylpiperidine
4-(5H-Dibenzo(a,D)cyclohepten-5-ylidene)-1-methylpiperidine
4-(5H-Dibenzo(a,d)cyclohepten-5-ylidene)-1-methylpiperidene
4-(5H-Dibenzo(a,d)cyclohepten-5-ylidene)-1-methylpiperidine
4-(5H-Dibenzo[a,d]cyclohepten-5-ylidene)-1-methylpiperidine
4-(5H-dibenzo[a,d][7]annulen-5-ylidene)-1-methylpiperidine
4-Dibenzo[a,D]cyclohepten-5-ylidene-1-methyl-piperidine
41354-29-4
5-(1-Methylpiperidylidene-4)-5H-dibenzo(a,d)cyclopheptene
5-(1-methylpiperidylidene-4)-5H-dibenzo(a,d)cyclopheptene
5-20-08-00500 (Beilstein Handbook Reference)
AC1L1ER8
AKOS004119847
Axoprol
BIDD:GT0324
BPBio1_000096
BPBio1_000155
BRD-K28143534-001-01-4
BRD-K28143534-003-03-6
BRN 1685976
BSPBio_000086
Biomol-NT_000131
C06935
CAS-969-33-5
CCRIS 5232
CHEBI:4046
CHEMBL516
CID2913
CYPROHEPTADINE
Ciproheptadina
Ciproheptadina [INN-Spanish]
Ciprovit
Ciprovit (TN)
Cypoheptadine
Cyproheptadiene
Cyproheptadin
Cyproheptadine
Cyproheptadine (INN)
 
Cyproheptadine Hcl
Cyproheptadine Hydrochloride
Cyproheptadine [INN:BAN]
Cyproheptadinum
Cyproheptadinum [INN-Latin]
D07765
DB00434
Dibenzosuberonone/Cyproheptadine
Dihexazin
Dronactin
EINECS 204-928-9
Eiproheptadine
Glutodina
HMS2090P20
HSDB 3048
L001016
LS-114933
Lopac-C-6022
Lopac0_000246
MK 141
MolPort-002-507-777
NCGC00015252-01
NCGC00015252-02
NCGC00015252-03
NCGC00015252-09
NCGC00024293-02
NCGC00024293-04
NCGC00024293-05
Oprea1_498140
PDSP1_001229
PDSP2_001213
Periactin
Periactine
Periactinol
Prestwick0_000103
Prestwick1_000103
Prestwick2_000103
Prestwick3_000103
SPBio_002025
STK802098
Tocris-0996
UNII-2YHB6175DO
Viternum
nchembio.559-comp10
2
Histamine PhosphateapprovedPhase 390651-74-165513
Synonyms:
1H-Imidazole-4-ethanamine, phosphate (1:2)
2-Imidazol-4-ylethylamine orthophosphoric acid (1:2)
4-(2-Aminoethyl)imidazole bis(dihydrogen phosphate)
4-(2-Aminoethyl)imidazole di-acid phosphate
4-2(2-Aminoethyl)Imidazole-Di-Acid Phosphate
51-74-1
53623-99-7
74-56-6
AC1L23E4
CID65513
D04445
DB00667
EINECS 200-118-4
 
H0147
Histamine Positive Skin Test Control
Histamine Positive skin test control
Histamine acid phosphate
Histamine biphosphate
Histamine dihydrogen phosphate
Histamine diphosphate
Histamine phosphate (1:2)
Histamine phosphate (TN)
Histamine phosphate (USP)
Histamine phosphate [USP]
Histamine positive
Histaminum
LS-78569
UNII-QWB37T4WZZ
3Neurotransmitter AgentsPhase 314795
4
SerotoninPhase 3314750-67-95202
Synonyms:
3-(2-Aminoethyl)-1H-indol-5-ol
3-(2-Aminoethyl)indol-5-ol
3-(b-Aminoethyl)-5-hydroxyindole
5-HT
5-HTA
5-Hydroxy-3-(b-aminoethyl)indole
 
5-Hydroxy-tryptamine
5-Hydroxyltryptamine
5-Hydroxytriptamine
5-Hydroxytryptamine
Antemovis
DS substance
Enteramin
Enteramine
5Anti-Allergic AgentsPhase 31312
6Serotonin AntagonistsPhase 31175
7Histamine H1 AntagonistsPhase 3688
8Serotonin AgentsPhase 32668
9Histamine AntagonistsPhase 3826
10Dermatologic AgentsPhase 34555
11AntipruriticsPhase 3619
12
histaminePhase 390675614-87-8, 51-45-6774
Synonyms:
.beta.-Imidazolyl-4-ethylamine
1H-Imidazole-4-ethanamine
1H-Imidazole-5-ethanamine
1avn
1qft
2-(1H-Imidazol-4-yl)ethanamine
2-(1H-Imidazol-4-yl)ethylamine
2-(1H-Imidazol-5-yl)ethanamine
2-(1H-Imidazol-5-yl)ethylamine
2-(1H-imidazol-4-yl)ethan-1-amine
2-(1H-imidazol-5-yl)ethanamine
2-(3H-Imidazol-4-yl)-ethylamine
2-(4-Imidazolyl)ethanamine
2-(4-Imidazolyl)ethylamine
2-Imidazol-4-yl-Ethylamine
2-Imidazol-4-ylethylamine
2-[4-Imidazolyl]ethylamine
4-(2-Aminoethyl)-1H-imidazole
4-(2-Aminoethyl)imidazole
4-Imidazoleethylamine
5-Imidazoleethylamine
51-45-6
53290_FLUKA
64422-25-9
924364-91-0
AC-13185
AC1L19ZT
AC1Q54BV
AC1Q54BW
AKOS000274386
ALBB-005968
BCBcMAP01_000250
BSPBio_001117
BSPBio_002124
Bio1_000487
Bio1_000976
Bio1_001465
Bio2_000389
Bio2_000869
C00388
CCRIS 6535
CHEBI:18295
CHEMBL90
CID774
D08040
DivK1c_000308
EINECS 200-100-6
Eramin
Ergamine
Ergotidine
F411C768-A159-4FC0-A195-291A08BB03AA
Free histamine
H7125_SIGMA
HMS1362G19
HMS1792G19
HMS1990G19
HSDB 3338
HSM
Histamine
Histamine (DCF)
Histamine Base
Histamine [USAN]
Histamine, Free Base
Histaminum
 
Histaminum (TN)
IDI1_000308
IDI1_002144
Imidazole-4-ethylamine
Istamina
Istamina [Italian]
KBio1_000308
KBio2_000457
KBio2_001325
KBio2_003025
KBio2_003893
KBio2_005593
KBio2_006461
KBio3_000853
KBio3_000854
KBio3_001344
KBioGR_000457
KBioGR_001580
KBioSS_000457
KBioSS_001325
L-Histamin base
L-Histamine
L-histamine
L000292
LS-75835
Lopac-H-7250
Lopac0_000595
MLS000069447
MolPort-001-785-597
MolPort-002-042-264
NCGC00015513-01
NCGC00015513-08
NCGC00093371-02
NCGC00093371-03
NCGC00093371-04
NCGC00093371-05
NINDS_000308
NSC 33792
NSC33792
SDCCGMLS-0066601.P001
SMP1_000151
SMR000059091
SPBio_000729
ST073926
STK346752
STOCK5S-55669
Spectrum2_000665
Spectrum3_000452
Spectrum4_000960
Spectrum5_000796
Spectrum_000845
Theramine
UNII-820484N8I3
WLN: T5M CNJ D2Z
ZERO/004089
[3H]histamine
b-Imidazolyl-4-ethylamine
beta-Aminoethylglyoxaline
beta-Aminoethylimidazole
beta-Aminothethylglyoxaline
beta-Imidazolyl-4-ethylamine
beta-aminothethylglyoxaline
bmse000744
histamine
nchembio.87-comp54
nchembio714-comp1
13Gastrointestinal AgentsPhase 36401
14
CrizotinibapprovedPhase 1, Phase 292877399-52-511626560, 10366136, 10366137, 10366138, 10366139, 10366140, 10366141
Synonyms:
(R)-Crizotinib
C-Met/HGFR Tyrosine Kinase Inhibitor PF-02341066
C-Met/Hepatocyte Growth Factor Receptor Tyrosine Kinase Inhibitor PF-02341066
Crizotinib
Crizotinibum
 
MET Tyrosine Kinase Inhibitor PF-02341066
PF 2341066
PF-02341066
PF-2341066
Xalkori
crizotinib
15Protein Kinase InhibitorsPhase 1, Phase 23162
16
TrioxsalenapprovedPhase 1403902-71-45585
Synonyms:
2',4,8-Trimethylpsoralen
4,5',8-Trimethylpsoralen
4,8,5'-Trimethylpsoralen
6-Hydroxy-beta,2,7-trimethyl-5-benzofuranacrylic acid, delta-lactone
Trimethylpsoralen
Trioxisaleno
 
Trioxsalen
Trioxysalen
Trioxysalene
Trioxysalenum
Trisoralen
trimethylpsoralen
trioxysalen
trisoralen
17
Verteporfinapproved, investigationalPhase 183129497-78-55362420
Synonyms:
Verteporfin
Verteporfina
 
Verteporfinum
Vertéporfine
Visudyne
18Dihematoporphyrin EtherPhase 140
19
Octreotideapproved, investigational19883150-76-9383414, 6400441
Synonyms:
(4R,7S,10S,13R,16S,19R)-10-(4-aminobutyl)-19-[[(2R)-2-amino-3-phenylpropanoyl]amino]-16-benzyl-N-[(2R,3R)-1,3-dihydroxybutan-2-yl]-7-[(1R)-1-hydroxyethyl]-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carboxamide
10-(4-Aminobutyl)-19-((2-amino-3-phenylpropanoyl)amino)-16-benzyl-7-(1-hydroxyethyl)-N-(2-hydroxy-1-(hydroxymethyl)propyl)-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaa
10-(4-aminobutyl)-19-[(2-amino-3-phenylpropanoyl)amino]-16-benzyl-N-(1,3-dihydroxybutan-2-yl)-7-(1-hydroxyethyl)-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carboxamide
10-(4-aminobutyl)-19-[(2-amino-3-phenylpropanoyl)amino]-16-benzyl-N-[(2R,3R)-1,3-dihydroxybutan-2-yl]-7-(1-hydroxyethyl)-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carboxamide
79517-01-4 (acetate salt)
83150-76-9
AC1L1GVU
AC1L8LCD
AC1L9M4X
C07306
C5H12O2.C4H10
CHEBI:427278
CHEBI:611465
CHEMBL1680
CID383414
CID448601
CID54374
D-Phenylalanyl-L-cysteinyl-L-phenylalanyl-D-tryptophyl-L-lysyl-L-threonyl-L-cysteinyl-L-threoninol cyclic (2-7)-disulfide
D-Phenylalanyl-L-cysteinyl-L-phenylalanyl-D-tryptophyl-L-lysyl-L-threonyl-N-((1R,2R)-2-hydroxy-1-(hydroxymethyl)propyl)-L-cysteinamide cyclic (2-7)-disulfide
D-Phenylalanyl-L-cysteinyl-L-phenylalanyl-D-tryptophyl-L-lysyl-L-threonyl-N-((1R,2R)-2-hydroxy-1-(hydroxymethyl)propyl)-L-cysteinamide cyclic (2->7)-disulfide
D00442
DRG-0115
HMS2090C09
HS-2020
L-Cysteinamide, D-phenylalanyl-L-cysteinyl-L-phenylalanyl-D-tryptophyl-L-lysyl-L- threonyl-N-(2-hydroxy-1-(hydroxymethyl)propyl)-, cyclic (2->7)-disulfide, (R-(R*
L000453
 
LS-177735
LS-187135
Longastatin
NCGC00181796-01
NCI60_025753
Ocphyl
Octreotida
Octreotida [Spanish]
Octreotide
Octreotide (USAN/INN)
Octreotide Acetate
Octreotide Acetate Salt
Octreotide [USAN:INN:BAN]
Octreotide acetate
Octreotide-LAR
Octreotidum
Octreotidum [Latin]
Octrotide
SAN 201-995
SM 201-995
SMS 201-995
SMS-201-995
Sandostatin
Sandostatine
Sandoz 201-995
UNII-RWM8CCW8GP
nchembio.184-comp3
zacycloicosane-4-carboxamide acetate
20Edotreotide20
21Radiopharmaceuticals362
22Fluorides364
23Dihydroxyphenylalanine123

Interventional clinical trials:

idNameStatusNCT IDPhase
1Cyproheptadine in Preventing Weight Loss in Children Receiving Chemotherapy for CancerTerminatedNCT01132547Phase 3
2Crizotinib in Treating Young Patients With Relapsed or Refractory Solid Tumors or Anaplastic Large Cell LymphomaActive, not recruitingNCT00939770Phase 1, Phase 2
3Imetelstat Sodium in Treating Young Patients With Refractory or Recurrent Solid Tumors or LymphomaCompletedNCT01273090Phase 1
4Photodynamic Therapy With Porfimer Sodium in Treating Patients With Refractory Brain TumorsRecruitingNCT00002647Phase 1
5Efficacy of 68Ga-DOTATOC Positron Emission Tomography (PET) CT in Children and Young Adults With Brain TumorsSuspendedNCT02194452
618F FDOPA PET/CT or PET/MRI in Measuring Tumors in Patients With Newly Diagnosed or Recurrent GliomasTerminatedNCT02175745

Search NIH Clinical Center for Gemistocytic Astrocytoma

Genetic Tests for Gemistocytic Astrocytoma

About this section

Anatomical Context for Gemistocytic Astrocytoma

About this section

MalaCards organs/tissues related to Gemistocytic Astrocytoma:

33
Brain, Breast, Kidney, Spinal cord, Ovary, Skin, Myeloid

Animal Models for Gemistocytic Astrocytoma or affiliated genes

About this section

MGI Mouse Phenotypes related to Gemistocytic Astrocytoma:

38
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00020068.9ERCC1, IDH2, PTEN, PTGS1, RRAS, TERT
2MP:00053698.0CXCL12, ERCC1, GFAP, PTEN, PTGS1, S100A1
3MP:00028737.1CXCL12, GFAP, ITGA2, PTEN, S100A1, S100B
4MP:00053867.0ENO2, ERCC1, GFAP, ITGA2, PTEN, PTGS1
5MP:00053876.8CXCL12, ERCC1, GFAP, IDH1, ITGAM, PTEN
6MP:00053976.7CXCL12, ERCC1, IDH1, ITGA2, ITGAM, PTEN
7MP:00053766.3ERCC1, GFAP, IDH1, ITGA2, ITGAM, PTEN
8MP:00053846.2CXCL12, ENO2, ERCC1, GFAP, ITGA2, ITGAM

Publications for Gemistocytic Astrocytoma

About this section

Articles related to Gemistocytic Astrocytoma:

(show all 15)
idTitleAuthorsYear
1
Alterations of the RRAS and ERCC1 genes at 19q13 in gemistocytic astrocytomas. (25192052)
2014
2
Perfusion MR imaging and MR spectroscopy of gemistocytic astrocytoma. (22115534)
2012
3
Unusual synchronous presentation of maxillary sinus fibrosarcoma and gemistocytic astrocytoma with a complication called leukocytoclastic vasculitis: a case report. (19756200)
2009
4
Immunohistochemical features of a feline spinal cord gemistocytic astrocytoma. (18987242)
2008
5
Cytologic characteristics of subependymal giant cell astrocytoma in squash smears: morphometric comparisons with gemistocytic astrocytoma and giant cell glioblastoma. (17536538)
2007
6
Congenital gemistocytic astrocytoma in a fetus. (15864706)
2006
7
Gemistocytic astrocytomas: histomorphology, proliferative potential and genetic alterations--a study of 32 cases. (16614946)
2006
8
November 2003: neonatal female with congenital brain tumor. Congenital gemistocytic astrocytoma. (15193038)
2004
9
Genotype-phenotype correlation in gemistocytic astrocytomas. (11152345)
2001
10
p53 and PTEN gene mutations in gemistocytic astrocytomas. (9650746)
1998
11
Multiple primary malignant tumours: gemistocytic astrocytoma with leptomeningeal spreading and papillary thyroid carcinoma. A case report. (2251958)
1990
12
Gemistocytic astrocytoma in a one-month-old llama. (2365629)
1990
13
A gemistocytic astrocytoma demonstrated high intensity on MR images. Protein hydration layer. (2398944)
1990
14
Development of Hodgkin's disease in a patient receiving procarbazine, CCNU, and vincristine therapy for a gemistocytic astrocytoma. (626997)
1978
15
Gemistocytic astrocytoma: cytological observations on the rate of hydrolysis of some phosphoric acid esters. (13301910)
1955

Variations for Gemistocytic Astrocytoma

About this section

Expression for genes affiliated with Gemistocytic Astrocytoma

About this section
Search GEO for disease gene expression data for Gemistocytic Astrocytoma.

Pathways for genes affiliated with Gemistocytic Astrocytoma

About this section

GO Terms for genes affiliated with Gemistocytic Astrocytoma

About this section

Cellular components related to Gemistocytic Astrocytoma according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1PML bodyGO:00166059.6PTEN, TERT, TP53

Biological processes related to Gemistocytic Astrocytoma according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
12-oxoglutarate metabolic processGO:000610310.3IDH1, TAT
2tricarboxylic acid cycleGO:000609910.3IDH1, IDH2
3long-term synaptic potentiationGO:006029110.0PTEN, S100B
4replicative senescenceGO:00903999.7TERT, TP53
5response to organic cyclic compoundGO:00140709.0IDH1, ITGA2, PTEN, TAT

Sources for Gemistocytic Astrocytoma

About this section
2CDC
14ExPASy
15FDA
16FMA
24GTR
25HGMD
26HMDB
27ICD10
28ICD10 via Orphanet
29ICD9CM
30IUPHAR
31KEGG
34MedGen
36MeSH
37MESH via Orphanet
38MGI
41NCI
42NCIt
43NDF-RT
46NINDS
47Novoseek
49OMIM
50OMIM via Orphanet
54PubMed
55QIAGEN
60SNOMED-CT via Orphanet
64Tumor Gene Family of Databases
65UMLS
66UMLS via Orphanet